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Toxoplasma gondii is an obligate intracellular parasite causing severe diseases
in immunocompromised individuals and congenitally infected neonates, such as
encephalitis and chorioretinitis. This study aimed to determine whether serum metabolic
profiling can (i) identify metabolites associated with oocyst-induced T. gondii infection
and (ii) detect systemic metabolic differences between T. gondii-infected mice and
controls. We performed the first global metabolomics analysis of mice serum challenged
with 100 sporulated T. gondii Pru oocysts (Genotype II). Sera from acutely infected
mice (11 days post-infection, dpi), chronically infected mice (33 dpi) and control mice
were collected and analyzed using LC-MS/MS platform. Following False Discovery
Rate filtering, we identified 3871 and 2825 ions in ESI+ or ESI− mode, respectively.
Principal Component Analysis (PCA) and Partial Least Squares Discriminant Analysis
(PLS-DA) identified metabolomic profiles that clearly differentiated T. gondii-infected
and -uninfected serum samples. Acute infection significantly influenced the serum
metabolome. Our results identified common and uniquely perturbed metabolites and
pathways. Acutely infected mice showed perturbations in metabolites associated with
glycerophospholipid metabolism, biosynthesis of amino acid, and tyrosine metabolism.
These findings demonstrated that acute T. gondii infection induces a global perturbation
of mice serum metabolome, providing new insights into the mechanisms underlying
systemic metabolic changes during early stage of T. gondii infection.
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INTRODUCTION
Toxoplasma gondii is an important intracellular protozoan parasite that is able to cause encephalitis
in immuno-compromised individuals, chorioretinitis in immunocompetent patients and abortion
in pregnant women (Montoya and Remington, 1996; Yarovinsky, 2014). Reproductive disorders,
with teratogenic effects, abortions, and stillbirths are the main economic impact of T. gondii on
Zhou et al. Serum Metabolomic Signatures during Toxoplasmosis
livestock. Among the food animals, T. gondii infections are
more prevalent in pigs, sheep, and goats than in cattle (Lopes
et al., 2013). The life cycle of this parasite involves asexual
phase in intermediate vertebrate host and sexual phase occurs
exclusively in the intestinal epithelium of the definitive felid host
(Sullivan and Jeffers, 2012). Sexual reproduction results in the
formation and shedding of unsporulated (uninfective) oocysts,
which become infectious/sporulated within a few days (Dubey
et al., 2011). Sporulated oocysts can survive for 18 months in
soil (Frenkel et al., 1975), remain infectious for mice when stored
at 4◦C for 24 months in seawater (Lindsay and Dubey, 2009)
and have a remarkable ability to survive under adverse climatic
conditions (Dumètre et al., 2013). Although ingestion of T. gondii
cysts-contaminated meat has been the primary source of human
infection, improvement in animal management and husbandry
practice has significantly reduced T. gondii prevalence in meat
(Jones and Dubey, 2012). In the meantime, waterborne outbreaks
linked to drinking T. gondii oocysts-contaminated water have
been increasingly reported, posing a public health threat
(Boyer et al., 2011).
As an obligatory intracellular pathogen, T. gondii reproduces
by co-opting the resources of its host cells and inevitably
perturb the host cells at the transcription, protein and metabolite
levels. The complexity of host-T. gondii interactions requires
a system level understanding of the entire hierarchy of
biological interactions and dynamics. Therefore, several “omics”
techniques, including transcriptomics (Pittman et al., 2014),
proteomics (Zhou et al., 2013), and metabolomics (Zhou et al.,
2015, 2016b) have been developed and employed to interrogate
this intricate relationship between T. gondii and its host. Among
these “omics” platforms, metabolomics offers an advantage when
trying to decipher disease pathogenesis because metabolites are
more proximal to a phenotype than transcriptional or protein
information and thus can reflect the physiological status of
the human body, more than other omics-based approaches.
The ability to capture the global chemical changes makes
metabolomics a powerful bioanalytical tool to elucidate sites
of perturbations in biochemical pathways in any biological
system. We have previously utilized metabolomics to identify
biomarkers in the serum and brain of mice infected with T. gondii
cysts (Zhou et al., 2015, 2016b). Our recent studies enabled
the assessment of a broad range of endogenous metabolites
and identified perturbed biochemical pathways in response
to infection. However, it is still not well-understood which
metabolic pathways T. gondii uses for growth and multiplication
within the host. Also, despite the public health importance and
the key role that oocysts play in the life cycle of T. gondii
metabolic signature associated with T. gondii oocyst infection is
unknown.
Although T. gondii is an obligate intracellular parasite,
host serum offers an important window for understanding
host/parasite biology during infection. Moreover, metabolomic
analysis of serum samples provides a powerful tool for
phenotypic biology and clinical biomarker discovery, when
compared to in vitro studies of parasite biology. Aiming to
gain better insights into T. gondii pathogenesis and to identify
new biomarkers with potential diagnostic or therapeutic values
we have investigated the serum metabolic profile of mice
infected with T. gondii sporulated oocysts using non-targeted
LC-MS/MS approach. We successfully identified alterations in
several metabolites and specific metabolic pathways, such as
amino acid and energetic metabolism, in mice serum during
acute and chronic phases of T. gondii infection.
MATERIALS AND METHODS
Ethical Approval
The maintenance and care of experimental animals was carried
out in strict accordance with the Animal Ethics Procedures
and Guidelines of the People’s Republic of China. All animal
experiments used in this study were approved by Animal Ethics
Committee of Lanzhou Veterinary Research Institute, Chinese
Academy of Agricultural Sciences (Permit No. LVRIAEC2014-
002). All efforts have been made to alleviate suffering and
minimize the number of animals used in the study.
Oocyst Production and Purification
The majority of human toxoplasmosis cases were associated
with strains of a genotype II (Howe and Sibley, 1995). Oocysts
of T. gondii Pru strain (type II) were obtained and purified
according to a previously described method (Zhou et al.,
2016a). Briefly, tissue cysts of T. gondii Pru strain were
obtained from infected Kunming mice. After verification of
the tissue cyst status by histological examination, a 10-week-
old specific-pathogen-free kitten was fed with approximately
100 freshly prepared cysts (Zhou et al., 2016a). Feces of the
infected kitten were examined daily for the detection of the
oocysts. Oocysts were isolated from feces using a discontinuous
cesium chloride gradient method as previously described (Staggs
et al., 2009). To induce sporulation, the purified oocysts were
incubated in 2% H2SO4 and aerated on a shaker for 7 days
at ambient temperature. Sporulated oocysts were examined
with a light microscope (Olympus, Japan).Finally, the oocysts
were washed twice in 0.85% saline and were suspended
in 2% H2SO4 and stored in aliquots that were maintained
at 4◦C.
Mouse Infection
The mice used in this study were female, 6 to 8-week-
old, of the BALB/c strain, and were obtained from Lanzhou
University, China and were maintained under specific-pathogen-
free conditions in a standard experimental facility at Lanzhou
Veterinary Research Institute, Chinese Academy of Agricultural
Sciences. Mice received sterilized food and water ad libitum.
Twelve mice were infected orally with ∼100 freshly prepared
sporulated oocysts via oral gavage with 100 µL saline solution
using 1−ml tuberculin syringes and feeding needles. Six mock-
infected (control) mice received 100 µL saline alone. All mice
were monitored daily for mortality and morbidity throughout
the course of infection. At 11 and 33 days post-infection (dpi)
with T. gondii oocysts six mice were sacrificed. The infection
in each mouse was verified by PCR analysis of DNA extracted
frommice tissues, brain, blood, liver, spleen, lung, small intestine,
and kidney, targeting the B1 region of T. gondii as previously
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described (Hill et al., 2006). Also, mice spleen, kidney and liver
were collected and fixed in 10% buffered formalin (pH 7.2)
for 1 week followed by dehydration through a graded series
of alcohol to xylol and embedded in paraffin wax. Sections
of 5µm thick from paraffin wax blocks were cut and stained
with hematoxylin and eosin (H & E) for histopathological
analysis.
Serum Metabolite Extraction
The blood samples from acutely infected (11 dpi), chronically
infected (33 dpi) and control mice groups were prepared as
previously described (Wikoff et al., 2009). Briefly, blood samples
were obtained by retro-orbital bleed into Eppendorf tubes and
were allowed to clot for 3 h followed by centrifugation at
3,000 g for 10min at 4◦C. Sera were frozen immediately in
liquid nitrogen and stored at −80◦C until use for metabolite
extraction. Initially, frozen serum samples were placed at −20◦C
for 30min and then thawed at 4◦C. Serum sample aliquots
(40 µL) were treated with 120 µL methanol (3:1 vol/vol) and
mixed for 1min. The mixture was kept at −20◦C for 30min,
followed by centrifugation at 4,000 g for 20min at 4◦C. The
supernatant (20 µL) was mixed with 180 µL methanol before
liquid chromatography separation.
UPLC-MS/MS Analysis
Liquid chromatography was performed on a 2777CUPLC system
(Waters, UK). The separation of all samples was performed
on an ACQUITY UPLC BEH C18 column (Waters, U.K.)
(100 × 2.1mm, 1.7µm). A gradient elution program was
run for chromatographic separation with mobile phase A
(water) and mobile phase B (acetonitrile) as follows: 0∼2min,
100%A-100%A; 2∼11min, 100%A-0%A; 11∼13min, 0%A-0%A;
13∼15min, 0% A-100%A. The injection volume was 10 µL
and the flow rate was set as 0.4 mL/min. A SYNAPT G2 XS
QTOF (Waters, UK) equipped with an electrospray ionization
(ESI) source was used for mass spectrometric detection. Sample
analysis was performed in both positive and negative ion modes.
The operating parameters were as follows: capillary, 3kV(ESI+)
or 0.33 kV(ESI−); sampling cone: 40V; source temperature:
110◦C (ESI+) or 120◦C (ESI−); desolvation temperature: 550◦C
(ESI+) or 400◦C (ESI−); desolvation gas, 800 (L/h) (ESI+) or
500 (L/h) (ESI−); cone gas, 55 (L/h) (ESI+) or 60 (ESI−);
source offset: 80; TOF acquisition mode: sensitivity (ESI+) or
sensitivity (ESI−); acquisition method, continuum MSE; TOF
mass range: 50–1,200 Da; scan time: 0.2 s; collision energy
function 2: trap CE ramp 20 to 40 eV. Quality control (QC)
samples were used in order to assess the reproducibility and
reliability of the LC-MS/MS system. QC samples were prepared
by mixing equal volumes (20 µL) from each serum sample
as they were aliquoted for analysis. This “pooled” sample was
used to provide a “mean” profile representing all analytes
encountered during the analysis. The pooled “QC” sample was
run 10 times at the beginning of the analysis and then prior
to and after each batch of 10 serum samples to ensure system
equilibration.
Data Processing and Analysis
Raw data files were uploaded into Progenesis QI 2.1
software (Waters Corp., Manchester, UK), which was used
to perform untargeted peak detection, peak alignment, peak
grouping, normalization, and integration on each full data
set (experimental study samples and QC samples). Then,
the data matrix was mean-centered and Pareto-scaled prior
to multivariate analysis (MVA) using Principal Component
Analysis (PCA) and Partial Least Squares Discriminant Analysis
(PLS-DA). PCA and PLS-DA were performed to discriminate
infected from control mice. The quality of the models was
evaluated with the relevant R2 andQ2 as discussed elsewhere (Lee
et al., 2003). The non-parametric univariate method (two-tailed
Wilcoxon rank-sum test) was used to discover the significantly
altered metabolites among the infected and healthy control
mice. The results were corrected by false discovery rate (FDR)
to ensure that metabolite peaks were reproducibly detected.
The differential metabolites were selected when the statistically
significant threshold of variable importance in the projection
(VIP) values obtained from the PLS-DA model were larger than
1.0 (Emond et al., 2013). Statistically significant differences were
tested using Student’s t-test, and the corrected P-values (q-value)
<0.05 was deemed as statistically significant. Log2 fold change
(FC) was used to show how the selected differential metabolites
varied between the mice groups. Serum metabolites passing the
VIP threshold (VIP > 1) and fold change ≥1.2 or ≤0.8 were
considered as significantly different between the mice groups
(Feng et al., 2016).
Heatmaps were used to depict the relatively disturbed and
unbalanced metabolic signature among T. godnii-infected mice
compared to control mice. Heatmaps were generated using
the MultiExperiment Viewer (MeV) v. 4.9 software (http://
mev.tm4.org/) based on the abundance of the differentially
expressed metabolite data (log2-scaled) (Halama et al., 2015).
The online databases of Human Metabolome Database (HMDB;
http://www.hmdb.ca) and Kyoto Encyclopedia of Genes and
Genomes (KEGG; http://www.genome.jp/kegg) were used to
check and confirm the putative identity of the differentially
expressed metabolites by matching the exact molecular mass
data (m/z) of samples with those from the database (Wishart
et al., 2013; Du et al., 2014). The candidate metabolites
were confirmed by MS/MS scans for the characteristic ions
and fragmentation patterns of the compound. We performed
pathway analysis of the differentially expressed metabolites
detected in both ion modes using MetaboAnalyst 3.0 (Xia
et al., 2015). The identified pathways influenced by acute
infection compared to controls are presented according to
p-values from the pathway enrichment analysis (y-axis) and
pathway impact values from pathway topology analysis (x-
axis), with the most impacted pathways colored in red
color. To gain further insight into the underlying biological
mechanisms associated with infection, we performed the impact
value and –log (P) along with metabolic pathway analysis
(MetPA), the P-value represented the enrichment of certain
metabolites in a pathway (P ≤ 0.05 is indicative of significant
enrichment).
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RESULTS
Characteristics of Infected Mice
Purified sporulated oocysts used in this study are shown in
Figure S1. In infected mice, signs of illness started at 5–7 dpi and
peaked at 11 dpi when mice developed severe splenomegaly and
other signs consistent with acute infection, including anorexia,
weight loss, edema, and messy hair. As infection progressed
animals slowly started to recover and by 33 dpi infected
mice had restored their physical status and developed chronic
infection as indicated by the observation of T. gondii tissue
cysts in homogenized brains at 33 dpi (Figure S2). Infection
was confirmed via the detection of T. gondii B1 gene in various
mouse tissues of all infected mice (Table S1). Mice infected with
T. gondii exhibited a disruption of their splenic architecture.
Histopathological changes on day 11 post-infection included
a structural breakdown, reduced white pulp and increase in
the number of megakaryocytes (Figure S3A). On day 33 post
infection, the red and white pulp were observed. However,
the white pulp showed mild hyperplasia and some lymphoid
follicles tended to coalesce, and the red pulp was non-reactive
(Figure S3B). As expected, mice in the control group appeared
clinically normal during the experiment, were PCR-negative
for T. gondii infection and did not show any histopathological
abnormalities (Figure S3C).
Serum Metabolic Profiles
To access the capability of the LC-MS/MS based-metabolomics
approach used in this study we analyzed all total ion
chromatograms of QC samples, which exhibited a stable
retention time without obvious peaks’ drifts. There were 4,583
and 3,388 ions identified in each sample profile in ESI+ and ESI−
mode, respectively. After removing low-quality ions [relative
standard deviation (RSD)>30%], 3,871 and 2,825 ions in each
sample were identified in ESI+ or ESI− mode, respectively.
To assess the reproducibility of our dataset, QC samples were
measured during the entire experiment. PCA among the QC
samples and tested samples was performed and the two-
dimensional PCA score plots are shown in Figure S4. The results
showed that QC samples were clustered closely to each other
and were separated from the tested samples, confirming the
stability and reproducibility of the LC-MS/MS analysis. Next,
we compared the metabolic profiles across the different mice
groups by employing two dimensional PCA. Although acutely
infectedmice were clearly separated from the chronically infected
and control mice groups, PCA scores plots under both ion
modes did not clearly differentiate chronically infected mice
from control group in ESI+ mode (Figure 1A) and ESI− mode
(Figure 1B). Further multivariate analysis using cross-validated
two-dimensional PLS-DA models was performed, which showed
distinct separation of the three mice groups in ESI+ mode
(Figure 1C) and ESI−mode (Figure 1D).
Serum Metabolic Profiles Distinguish
between Acute and Chronic Toxoplasmosis
Score scatter plots for two-dimensional PLS-DA model from
both ion modes showed a clear differentiation of acutely infected
and control groups. The 12 serum samples are clustered based
on the relative MS intensity of these differential metabolite ions
detected in ESI+mode (Figure 2A) and ESI-mode (Figure S5A),
which clearly revealed two distinct clusters, corresponding
to acutely infected mice and control mice group. This clear
separation was also demonstrated in the heatmap based on the
12 serum samples in the ESI+ mode (Figure 2D) and the ESI−
mode (Figure S5D).
The scores plots of PLS-DA model clearly discriminated
chronically infected mice from control mice as shown in
Figure 2B (ESI+) and Figure S5B (ESI−), respectively.
Meanwhile, a heatmap constructed based on the significantly
differential metabolite ions detected in the ESI+ mode further
supported the distinct metabolic features between chronic
infection vs. control (Figure 2E). However, in the ESI− mode,
there was no any differential metabolite between chronically
infected and control mice. So, there is not a heat map for the
comparison between these two groups.
Likewise, two-component PLS-DA models showed good
discrimination between acute and chronic infection in both ion
modes: ESI+ mode (Figure 2C) and ESI− mode (Figure S5C).
Interestingly, heatmaps constructed based on differential
metabolite ions between acutely and chronically infected mice
groups showed a clear clustering (Figure 2F and Figure S5E),
which demonstrates the reliability of the PLS-DA models
to distinguish between different disease-specific metabolic
phenotypes.
Patterns of Differentially Abundant
Metabolites
As shown in Figure 3A, the serum metabolic profile in infected
mice changed significantly from the controls at 11 dpi (ESI+).
As the infection progresses the number of differential metabolites
decreased, indicating a restoration of the dysregulated metabolic
state in a time-dependent manner. Of the 758 differential
metabolites, 445 were common across the three comparison
pairs. The majority of the differential metabolites (410) were
common between AI vs. Con and AI vs. CI. Thirty-five
differential metabolites were detected between AI vs. Con and CI
vs. Con.Meanwhile, in the ESI−mode, the number of differential
metabolites identified between the acute infection group and
the controls was the largest (Figure 3B). By searching against
mass-based databases, some of these differential monoisotopic
ions were putatively identified. As shown in Figure 3C,
“glycerophospholipids,” “fatty acyls” and “carboxylic acids and
derivatives” were the most prominent categories between acutely
infected mice and controls in ESI+ mode. Meanwhile, “benzene
and substituted derivatives,” “fatty acyls” and “prenol lipid” were
the three most enriched categories between acutely infected and
control mice in ESI−mode (Figure 3D).
Many perturbed lipid metabolites belonging to
glycerophospholipids (Figure 4A). Comparison between
chronically infected and control mice showed fatty acyls,
benzenes, steroids, and glycerophospholipids as the top 4 most
enriched metabolite classes in the ESI+ mode (Figure S6).
However, in the ESI− mode no differential metabolites were
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FIGURE 1 | Differential metabolic profiles of mice serum during the course of T. gondii infection. Principal component analysis (PCA) score scatter plots of metabolites
obtained from LC-QTOF-MS/MS fingerprints in ESI+ (A) and ESI− mode (B). Partial least-squares discriminant analysis (PLS-DA) separating metabolites of the three
groups in ESI+ mode (C) and ESI− mode (D). Acutely infected group (AI, red), chronically infected group (CI, green) and control group (Con, blue). Ellipses enclose
the 95% confidence intervals estimated by the sample means and covariances of each group.
detected between chronically infected and control mice.
Amine-containing metabolites are involved in many biological
processes, especially in amino acid and nucleotide metabolic
pathways. As shown in Figure 4B, 26 amine-containing
metabolites were found perturbed in comparison between
different infection groups. As shown in Table 1, we detected 35
metabolites in ESI+ mode that varied at both acute and chronic
infection stages. Traumatin, a metabolite of the α-linoleic acid
pathway, is the only metabolite that showed up-regulated levels
during the whole infection course especially during the acute
stage.
Altered Metabolic Pathways and Their
Biological Significance
The biological pathways involved in the metabolism of the
differentially expressed metabolites and their biological roles
were determined by enrichment analysis using MetaboAnalyst.
Six perturbed metabolic pathways showed lower p-values and
higher pathway impact between acutely infected and control mice
(Figure 5A). These included pathways related to metabolism of
glycerophospholipid, pantotherate andCoA biosynthesis, retinol,
linoleic acid, citrate cycle, and vitamin B6. Metabolism and
biosynthesis of several amino acid were significantly perturbed
during T. gondii acute infection (Figure 5B). Differential
metabolites between acutely infected and control mice, involved
in amino acid metabolism, were determined and detailed
information is listed in Table S2. Interestingly, L-glutamine,
a metabolite involved in mitochondrial metabolism, was up-
regulated. Through the KEGG analysis, we found uric acid
and hypoxanthine perturbed in purine metabolism, and orotate,
3-hydroxypropionate, ctidine, and UppppU were affected in
pyrimidine metabolism (Figure 5C).
Among infection-related dysregulated pathways, “alanine,
aspartate and glutamate metabolism,” “glycerophospholipid
metabolism,” “terpenoid backbone biosynthesis,” and “retinol
metabolism” were the top 4 perturbed metabolic pathways
between acutely and chronically infected mice (Figure S7).
Meanwhile, 13 metabolites, gentisic acid, imidazole acetol-
phosphate, (R) 2,3-dihydroxy-3-methylvalerate, L-tyrosine,
L-glutamine, L-arginine, citrulline, DL-dopa, 5-hydroxy-2-
oxo-4-ureido-2,5-dihydro-1H-imidazole-5-carboxylate, L-
cystathionine, indoleacetaldehyde, 5-hydroxykynurenamine and
3-methyl-1-hydroxybutyl-ThPP were altered and involved in
amino acid metabolism (Table S3).
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FIGURE 2 | Discrimination between acutely infected, chronically infected and control mice based on ESI+ mode-derived metabolic phenotype of serum. (A–C) Partial
least squares-discriminate analysis (PLS-DA) score plots of (A) acutely infected vs. control, (B) chronically infected vs. control and (C) acutely infected vs. chronically
infected. (D–F) Heat maps of the top differential metabolites for (D) acutely infected vs. control, (E) chronically infected vs. control and (F), acutely infected vs.
chronically infected. Sample groups including acutely infected, chronically infected and control, are labeled AI, CI, and Con, respectively.
FIGURE 3 | Comparison of metabolomics data across T. gondii infection state. Venn diagrams displaying (comparatively) the differentially expressed metabolites. All
differentially expressed metabolites are clustered into three comparison groups represented by three circles. The sum of all the figures in one circle represents the
number of differentially expressed metabolites in one comparison group (e.g., AI vs. CI). The overlapping parts of different circles represent the number of differentially
expressed metabolites shared between these comparison groups. The single-layer part represents the number of metabolites distinctly found in a certain comparison
group. (A,B) Differential metabolites across comparison groups showing unique and common metabolites in (A) ESI+ mode and (B) ESI− mode. (C) Top 15 enriched
metabolite terms of acutely infected vs. control in ESI+ mode. (D) Top 10 enriched metabolite terms of chronically infected vs. control in ESI− mode. Red and green
metabolites indicate higher and lower concentrations, respectively. The bars on x-axis represent the number of metabolites for the chemical classes mentioned on the
y-axis.
DISCUSSION
Infections by T. gondii are widely prevalent in human beings
and animals world wide. It has been reported that the majority
of human toxoplasmosis cases were associated with strains of
a genotype II (Dardé et al., 1992; Howe and Sibley, 1995).
In food animals, most of the T. gondii isolates thus far have
been of type II or III (Literák et al., 1998; Mondragon et al.,
1998; Owen and Trees, 1999). The oral route is the natural
route for acquiring human and animal pathogen T. gondii
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FIGURE 4 | Comparison of glycerophospholipid and amine-containing metabolite levels at different infection stages. (A) Heat map of 40 glycerophospholipids during
the whole infection process. CPA, cyclic phosphatidic acid; LPA, lysophosphatidic acid; PC, phosphatidylcholines; PE, phosphatidylethanolamines; PG,
phosphatidylglycerols; PS, phosphatidylserines. (B) Heat map of 26 significant amine-containing metabolites during the whole infection course. The color of each
section corresponds to an abundance value of each metabolite calculated by peak area normalization method. Each row represents data for a specific metabolite and
each column represents acutely infected (AI), chronically infected (CI) or Control (Con) mouse group. Different colors correspond to the different intensity level of
metabolites.
and infection via the consumption of water contaminated with
T. gondii oocysts has been frequently reported (Dubey, 2004;
Hill et al., 2011). However, knowledge about the pathophysiology
of oocyst-induced toxoplasmosis is still limited. Also, there is
a pressing need for new biomarkers that can reliably detection
infection and stratify patients infected with T. gondii oocysts.
Metabolomics offers a powerful means to investigate host-
parasite interactions at the biochemical level and to discover
novel biomarkers of infection (Lakshmanan et al., 2012; Zhou
et al., 2015, 2016b). In this study, a non-targeted LC-MS/MS-
based method was used to explore different metabolic signatures
of serum from mice during acute and chronic stage of oocyst-
induced toxoplasmosis compared with uninfected controls and
to identify metabolites and metabolic pathways that become
dysregulated during T. gondii infection.
Clinical signs of infected mice were observed during the
whole infection process. Mice at 11 dpi showed typical signs
of acute infection, which was accompanied by the parasite
distribution throughout the whole body except muscles. As
infection progressed animals restored their health conditions
at 33 dpi where the parasites were only detected in the brain,
heart and muscle. These data indicate a correlation between
the severity of toxoplasmosis and parasite distribution. Plots
from the multivariate analyses (PCA and PLS-DA) clearly
showed time-course biosignatures of mice metabolic response
to T. gondii infection (Figure 1). As shown in Figure 2
and Figure S5, PLS-DA demonstrated clear separation among
different mice groups. Comparison of the serum metabolic
profiles of acutely infected and control mice showed marked
differences in the levels of metabolites belonged to lipids,
fatty acids, amino acids, products of amino acid metabolism,
nucleotides, benzenoids, phenylpropanoids, and alkaloids. These
results indicate that acute T. gondii infection can induce systemic
metabolic perturbations in the metabolism of several chemical
classes of macromolecules including traumatin, a product of
α-linolenic acid (ALA) metabolism, not previously known to
exist in T. gondii. In contrast, chronic infection did not seem
to significantly alter the serum metabolic profile; only minor
alterations were observed in fatty acyls, benzenes, steroids and
glycerophospholipids. These differences are consistent with our
previous metabolomics findings in mice infected with T. gondii
cysts (Zhou et al., 2015). Thirty-five metabolites detected in
ESI+ mode varied at acute and chronic infections. Except for
traumatin, all of these differential metabolites showed decreased
levels, which might be driven by the inappetence and decreased
food intake of infected mice.
To ensure its survival and maximize parasite replication
T. gondii modulates host cell environment, such as scavenging
lipid precursors from host cell for growth and membrane
biogenesis (Gupta et al., 2005; Bisanz et al., 2006). Lipids have
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TABLE 1 | List of dysregulated metabolites identified in ESI+ mode throughout the entire infection process.
MS (m/z) RT (min) Metabolites AI vs Con CI vs Con
VIP FC q-value CV VIP FC q-value CV
221.0199166 0.604766667 Hydroxyphenyllactic acid 1.83 0.346 1.93E03 ↓ 2.43 0.472 2.69E02 ↓
251.1041128 4.582316667 Traumatin 3.22 27.617 2.94E04 ↑ 2.61 2.34 2.69E02 ↑
280.0935614 0.604766667 Tolmetin 1.78 0.367 3.33E03 ↓ 2.14 0.56 3.98E02 ↓
303.2326059 8.339133333 Yucalexin A16 1.46 0.495 3.33E03 ↓ 2.10 0.583 1.70E02 ↓
305.2485248 8.467716667 Drostanolone 1.53 0.396 1.29E02 ↓ 2.47 0.468 4.75E02 ↓
343.2247794 8.339133333 2-Hydroxy-6-tridecylbenzoic acid 1.47 0.490 4.00E03 ↓ 2.12 0.578 1.70E2 ↓
357.1522945 8.339133333 xi-3-Hydroxy-5-phenylpentanoic acid
O-beta-D-Glucopyranoside
1.54 0.422 1.36E02 ↓ 2.31 0.519 1.70E2 ↓
359.0921059 8.7456 1-Hydroxypyrene glucuronide 1.25 0.590 3.21E03 ↓ 2.07 0.595 2.96E02 ↓
359.1541578 8.339133333 N2-Fructopyranosylarginine 1.51 0.454 5.85E03 ↓ 2.06 0.584 2.69E02 ↓
367.1431981 8.339133333 Labetalol 1.44 0.496 5.81E03 ↓ 2.06 0.594 1.70E2 ↓
371.2078265 8.339133333 (3S,7E,9S)-9-Hydroxy-4,7-megastigmadien-
3-one
9-glucoside
1.42 0.448 1.66E02 ↓ 2.23 0.527 1.77E02 ↓
377.1637462 8.32485 Trigoforin 1.52 0.436 9.74E03 ↓ 2.17 0.558 1.70E02 ↓
403.1617396 8.32485 Suxibuzone 1.16 0.575 2.22E02 ↓ 1.90 0.634 2.69E02 ↓
406.1726594 8.339133333 18-Carboxy-dinor-LTE4 1.52 0.456 7.16E03 ↓ 2.22 0.545 1.87E02 ↓
408.1700156 8.339133333 Trifluoperazine 1.53 0.441 8.24E03 ↓ 2.22 0.541 1.90E02 ↓
544.3394585 8.7456 LysoPC(20:4(5Z,8Z,11Z,14Z)) 1.43 0.487 2.83E03 ↓ 2.40 0.489 1.70E02 ↓
762.177347 8.7456 Valrubicin 1.21 0.603 9.75E03 ↓ 2.32 0.504 2.69E02 ↓
RT, Retention time; VIP, variable importance for projection; CV, Content variance; AI, CI, and Con denote acute infection group, chronic infection group, and control group; FC, Fold
change; q-value, adjusted p-value calculated by the two-tailed Wilcoxon rank-sum tests after false discovery rate correction. A single arrow (↑/↓) indicates increased or decreased
values compared to the control group.
various biological functions and are fundamental components of
biological membranes and organelles. We detected alterations
in fatty acyls and glycerophospholipids. Specifically, an increase
in a number of intermediates involved in glycerophospholipids
synthesis was noted and lysoPCs, lysoPEs, and PCs were the
top 3 perturbed metabolites (Figure 4A). Also, we observed a
reduction in the levels of the majority of lysophospholipids,
especially during acute infection. Lysophospholipids are
metabolite derivatives of membrane phospholipids via the action
of phospholipase A2 (PLA2) enzyme and serve as precursors
for inflammatory mediators (Libby et al., 2002). Hence, the
reduced concentration of lysophospholipids is likely to be due
to inhibition of PLA2, probably mediated by T. gondii as an
evasion mechanism to reduce the host inflammatory response
during acute infection. However, PLA2 is known to play a key
role in T. gondii infection (Gomez-Marín et al., 2002). Whether
T. gondii has a dual effect on PLA2, selectively inhibits the
production of inflammatory mediators without inhibiting the
beneficial properties of PLA2 to the parasite establishment,
remains to be investigated.
Interestingly, one of the putatively annotated differentially
abundant metabolites in our analysis belonged to a
plant-like ALA metabolism pathway. This metabolite,
annotated as traumatin (2-dodeceno-1-al-10-carboxylic
acid), showed increased levels especially during the acute
stage of infection. Traumatin has been also detected in
Plasmodium falciparum-infected human plasma (Lakshmanan
et al., 2012). Traumatin is the aldehyde derivative of the plant
hormone Traumatic acid (TA, trans-2-dodecenedioic acid), and
both are called wound hormones, because they appear in high
amount around wounds and can stimulate cell proliferation in
plants. TA plays an important role in the regulation of growth
and metabolism in water plant, Wolffiaarrhiza Wimm, which
was thought to maintain the redox balance to protect plant
cells from oxidative stress (Pietryczuk and Czerpak, 2012). TA
caused a reduction in membrane phospholipid peroxidation and
exhibited protective antioxidative properties against reactive
oxygen species (ROS) production as well as capacity to stimulate
human skin fibroblasts proliferation (Jabłonska-Trypuc´ et al.,
2016). The relative importance of traumatin in T. gondii infection
is still unknown. Traumatin can potentially have a novel role in
the interplay between T. gondii and host. Further investigation
will be needed to determine the significance of changes in
traumatin levels during T. gondii infection.
Biological amine-containing metabolites represent a large
group of organicmolecules including amino acids, other biogenic
amines, and signaling molecules, such as neurotransmitters.
They play essential roles in many biological functions. Their
identification and quantification in biofluids provided significant
insights into the pathogenesis of various diseases, such as
cancer, diabetes and Parkinson’s disease (Przedborski et al., 2000;
Dronavalli et al., 2008; Wang et al., 2013). Our results revealed
perturbations in 26 amine-containing metabolites involved in
amino acid and nucleotide (purine and pyrimidine) metabolic
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FIGURE 5 | Pathway analysis of the identified differential metabolites between acutely infected and control mice in ESI+ mode and ESI− mode. (A) Pathway impact
resulting from the differential metabolites using MetaboAnalyst 3.0. Small p-value and big pathway impact factor indicate that the pathway is greatly influenced.
(B) Distribution of differential metabolites involved in amino acid metabolism. (C) Schematic overview of the differential metabolites involved in purine metabolism and
pyrimidine metabolism. Red represents up-regulated metabolites, green represents down-regulated metabolites, and the open circles represent no change.
pathways. L-Arginine, an amino acid mainly metabolized either
by inducible nitric oxide synthases or by arginase 1 in myeloid
cells was found decreased during T. gondii infection. T. gondii
is an arginine auxotroph and arginine starvation was proven
to efficiently trigger differentiation of replicative tachyzoites
into bradyzoites contained within cyst-like structures (Fox
et al., 2004). As shown in Table S2, the levels of 4 differential
metabolites, L-tyrosine, 4-hydroxycinnamic acid, gentisic acid,
and homogentisic acid, decreased. The increased serum level
of the essential amino acid phenylalanine (Phe) together with
elevated Phe to tyrosine (Tyr) ratio is also interesting. This
finding is expected because inflammatory responses associated
with T. gondii infection may interfere with Phe metabolism and
diminishes the conversion of Phe to Tyr, probably via impairment
of the phenylalanine-hydroxylase (PAH), rate-limiting in the
biosynthesis of dopamine. Thus, our finding is in agreement
with previous reports relating behavioral changes in mice or
psychiatric problems in humans infected with T. gondii to
effect of the parasite on the equilibrium of the neurotransmitter
dopamine (Elsheikha and Zhu, 2016). Although we did not
measure dopamine in our study a low level of dopamine can
be implied from the measured high Phe/Tyr ratio. This reduced
dopamine occurred during acute infection (11 dpi) is consistent
with previous reports where 14% increase in brain dopamine
levels was detected in mice upon establishment of chronic
infection (Stibbs, 1985); a result which was supported by the
increased level of serum dopamine in chronically infected mice
(Zhou et al., 2015).
The level of Tryptophan (Trp), another essential amino acid,
was found decreased in our study. This is biologically plausible
because Trp depletion via IFN-mediated IDO (Indoleamine 2,3-
dioxygenase, a key enzyme of Trp metabolism) induction has
been proposed as anti-parasitic response to deprive T. gondii
tachyzoites of this essential amino acid (Silva et al., 2002).
Inhibition of IDO can result in the rejection of allogenic
fetuses, which suggests tryptophan breakdown is necessary
for maintaining aspects of immune tolerance (Moffett and
Namboodiri, 2003). Trp also acts as a precursor for the synthesis
of the neurotransmitters melatonin and serotonin and hence,
any reduction in serum Trp levels will lead to a reduction
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in serotonin synthesis, which contributes to the occurrence of
psychopathological disorders. Although immune-related IDO
activation has been proposed as a defensemechanism for starving
T. gondii of Trp and inhibiting its growth this hypothesis can
be challenged because the upregulation of IDO activity and the
depletion of Trp did not seem to inhibit the parasite growth and
reproduction of malarial parasite in mice (Sanni et al., 1998).
Our results also showed interesting pathways associated with
infection, such as alanine, aspartate and glutamate metabolism
(Figure S7). This finding agrees with the previous observation
that T. gondii infection of pigs, significantly influences the
plasma levels of alanine aminotransferase (ALT) 21 and 32
days after infection with tachyzoites of RH strain (Miranda
et al., 2015). L-glutamine, as an important carbon source
when glucose uptake is inhibited during T.gondii infection,
was found upregulated in the acute infection stage. Glutamine
was catabolized via the oxidative tricarboxylic acid (TCA) cycle
and generates γ-aminobutyric acid and additional molecules
that are essential for the intracellular growth of T. gondii
(MacRae et al., 2012). Also, CCR5-deficient (CCR5−/−) mice
infected with T. gondii exhibited increased level of ALT 8 dpi
compared to uninfected mice (Bonfá et al., 2014). Additionally,
treatment with 6-trifluoromethyl-2-thiouracil (KH-0562) or
pyrimethamine was found to restore the elevated level of ALT
in infected mice to the normal level, which was thought to be
due to the anti-T. gondii activity and subsequent inhibition of
hepatotoxicity derived fromT. gondii infection (Choi et al., 2014).
Hypoxanthine and other purines are essential nutrients that the
intracellular T. gondii parasite salvages from the surrogate host
cell to sustain its growth and proliferation. Hypoxanthine was
found down-regulated, indicating that this compound is rapidly
consumed in purine biosynthesis during acute infection. Four
pyrimidine metabolites were identified: two upregulated (orotate
and 3-hydroxypropionate) and two downregulated (ctidine and
UpppU).
In conclusion, this study has demonstrated the ability of
LC-MS/MS-based metabolomics to detect a broad range of
differential metabolites in mice serum and to detected serum
metabolic signatures that strongly distinguished between acutely
and chronically infected mice. Our approach has enabled us
to confirm some of the known metabolites, as well as unravel
a hitherto undiscovered aspect of T. gondii pathobiology.
We revealed differential metabolites related to alterations in
metabolism of lipids (e.g., lysophospholipids) and amino acid
(phenylalanine, tyrosine, tryptophan, alanine, aspartate, and
glutamate). We also identified several dysregulated metabolic
pathways involved in the pathogenesis of T. gondii infection
including for the first time the existence of a plant-like traumatin
molecule, belonging to α-linolenic acid (ALA) pathway, known
to exist in plants but not known to exist in T. gondii until now.
Further studies will be required to more completely dissect the
relevance of the amine-containing metabolites identified in this
study and to investigate the presence of additional intermediates
of the plant ALA pathway in T. gondii–infected samples. It is
hoped that our findings add to the growing body of literature
that describes the application of “omics” methods to better
understand T. gondii biology and address relevant biological
and clinically important questions. Data generated from these
undertakings should foster our efforts toward discovering new
disease biomarkers and effective anti-T. gondii therapeutics.
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Figure S1 | Representative image of purified sporulated Toxoplasma gondii
oocysts used in the study.
Figure S2 | Toxoplasma gondii cyst recovered from homogenized mouse brain
tissue at 33 DPI.
Figure S3 | Histopathological changes in the splenic tissues from Toxoplasma
gondii-infected mice. Photomicrographs of splenic tissue sections stained with
hematoxylin and eosin (original magnification, ×100). (A) Spleen H&E section from
a mouse on day 11 postinfection. Spleen shows a loss and fusion of the germinal
centers in the white pulp and undefined boundary between the white pulp and the
red pulp. (B) On day 33 postinfection, spleen shows mild hyperplasia and some
lymphoid follicles tended to coalesce in the white pulp, whereas the red pulp was
non-reactive. (C) Spleen section from a healthy, uninfected mouse. Spleen shows
a normal histology with a clear structure of red (R) and white (W) pulps and normal
cell density.
Figure S4 | Principle component analysis (PCA) scores plots of serum samples
obtained from Toxoplasma gondii-infected mice compared to quality control (QC)
samples. (A) PCA scores plot for metabolites obtained in (A) positive ion mode
(ESI+) and (B) negative ion mode (ESI−). Blue dots indicate QC samples and
green dots indicate tested samples.
Figure S5 | Discrimination between acutely infected, chronically infected and
control mice based on ESI− mode-derived metabolic phenotype of serum. (A–C)
Partial least squares-discriminate analysis (PLS-DA) score plots of (A) acutely
infected vs. control, (B) chronically infected vs. control and (C) acutely infected vs.
chronically infected. (D–E) Heat maps of the top differential metabolites for (D)
Frontiers in Microbiology | www.frontiersin.org 10 January 2018 | Volume 8 | Article 2612
Zhou et al. Serum Metabolomic Signatures during Toxoplasmosis
acutely infected vs. control and (E) acutely infection vs. chronically infected.
Abbreviations: AI, acutely infected; CI, chronically infected; Con, control.
Figure S6 | Top 15 enriched metabolite classes identified between the chronically
infected and control mice in ESI+ mode. Red and green color indicate up- and
down-regulated metabolites, respectively. The bars on x-axis represent the
number of metabolites for the chemical classes mentioned on the y-axis.
Figure S7 | Summary of aberrant pathways of the significantly altered metabolites
between acutely infected and chronically infected mice as analyzed by
MetaboAnalyst. Plot shows the matched pathways depicted according to p-value
from pathway enrichment analysis and pathway impact score from pathway
topology analysis. Color gradient and circle size indicate the significance of the
pathway ranked by p-value (yellow: higher p-values and red: lower p-values) and
pathway impact score (the larger the circle the higher the impact score),
respectively. Significantly affected pathways with low p-value and high pathway
impact score are identified by name.
Table S1 | Detection of T. gondii by PCR amplification.
Table S2 | List of dysregulated metabolites involved in amino acid metabolism
between acutely infected and control groups.
Table S3 | List of dysregulated metabolites involved in amino acid metabolism
between acutely infected and chronically infected
groups.
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